These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 1634602)

  • 21. Growth factors in experimental osteoarthritis: transforming growth factor beta pathogenic?
    van den Berg WB
    J Rheumatol Suppl; 1995 Feb; 43():143-5. PubMed ID: 7752121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor-beta as a target for treatment in diabetic nephropathy.
    Basile DP
    Am J Kidney Dis; 2001 Oct; 38(4):887-92. PubMed ID: 11576897
    [No Abstract]   [Full Text] [Related]  

  • 23. Transforming growth factor-β and the kidney revisited: introduction.
    Lin HY
    Semin Nephrol; 2012 May; 32(3):225-7. PubMed ID: 22835452
    [No Abstract]   [Full Text] [Related]  

  • 24. Cyclosporin A induces proliferation in human gingival fibroblasts via induction of transforming growth factor-beta1.
    Cotrim P; Martelli-Junior H; Graner E; Sauk JJ; Coletta RD
    J Periodontol; 2003 Nov; 74(11):1625-33. PubMed ID: 14682659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Platelet-derived growth factor].
    Miyazono K
    Nihon Naika Gakkai Zasshi; 1992 Jan; 81(1):117-21. PubMed ID: 1556455
    [No Abstract]   [Full Text] [Related]  

  • 26. Practice pearl: a novel use of rifampicin for treatment of carpal tunnel syndrome.
    Namazi H
    J Pain; 2008 Apr; 9(4):380-1. PubMed ID: 18262848
    [No Abstract]   [Full Text] [Related]  

  • 27. Transforming growth factor-beta in glomerular injury.
    Border WA; Noble NA
    Exp Nephrol; 1994; 2(1):13-7. PubMed ID: 8081992
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of FK778 on acute rat renal allograft rejection and expression of platelet-derived growth factor and transforming growth factor-beta.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Transplant Proc; 2006 Oct; 38(8):2719-21. PubMed ID: 17098049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of action of the calcineurin inhibitors.
    Halloran PF
    Transplant Proc; 2001; 33(7-8):3067-9. PubMed ID: 11750319
    [No Abstract]   [Full Text] [Related]  

  • 30. [Transforming growth factor-beta: a new approach to the pathogenesis of glomerulonephritis and glomerulosclerosis].
    Witowski J; Knapowski J
    Przegl Lek; 1995; 52(9):467-73. PubMed ID: 8834649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of transforming growth factor beta in conjunctival scarring.
    Cordeiro MF
    Clin Sci (Lond); 2003 Feb; 104(2):181-7. PubMed ID: 12546640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Transforming growth factor-beta immunogenic participating in tuberculous pathogenesis].
    Shen Y; Li Z
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Mar; 23(3):181-2. PubMed ID: 11778491
    [No Abstract]   [Full Text] [Related]  

  • 33. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells.
    Matsuyama S; Iwadate M; Kondo M; Saitoh M; Hanyu A; Shimizu K; Aburatani H; Mishima HK; Imamura T; Miyazono K; Miyazawa K
    Cancer Res; 2003 Nov; 63(22):7791-8. PubMed ID: 14633705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of regulatory T cells by the immunomodulating cytokines alpha-melanocyte-stimulating hormone and transforming growth factor-beta2.
    Namba K; Kitaichi N; Nishida T; Taylor AW
    J Leukoc Biol; 2002 Nov; 72(5):946-52. PubMed ID: 12429716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenesis of glomerulosclerosis in light chain deposition disease. Role for transforming growth factor-beta.
    Zhu L; Herrera GA; Murphy-Ullrich JE; Huang ZQ; Sanders PW
    Am J Pathol; 1995 Aug; 147(2):375-85. PubMed ID: 7639331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Shh and TGF in cyclosporine-enhanced expression of collagen and α-SMA by gingival fibroblast.
    Chung Y; Fu E; Chin YT; Tu HP; Chiu HC; Shen EC; Chiang CY
    J Clin Periodontol; 2015 Jan; 42(1):29-36. PubMed ID: 25385493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Transforming Growth Factor Beta: structure, biologic effects and mechanism of action].
    Benzakour O
    Bull Cancer; 1994 Dec; 81(12):1014-22. PubMed ID: 7742590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transforming growth factor beta (TGF-beta) regulates the matrix-associated plasminogen activator inhibitor 1 (PAI-1) in glomerular mesangial and epithelial cells.
    Wilson HM; Reid FJ; MacLeod AM; Haites NE; Booth NA
    Exp Nephrol; 1995; 3(2):141-2. PubMed ID: 7773635
    [No Abstract]   [Full Text] [Related]  

  • 39. [TGF-beta signaling as a target of therapy].
    Komuro A; Miyazono K
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():256-62. PubMed ID: 23513847
    [No Abstract]   [Full Text] [Related]  

  • 40. FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach.
    Wu CS; Wu PH; Fang AH; Lan CC
    Br J Dermatol; 2012 Sep; 167(3):532-41. PubMed ID: 22540338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.